185 related articles for article (PubMed ID: 23967190)
1. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells.
Su A; He S; Tian B; Hu W; Zhang Z
PLoS One; 2013; 8(8):e71309. PubMed ID: 23967190
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1.
Li P; Liu Y; Yi B; Wang G; You X; Zhao X; Summer R; Qin Y; Sun J
Cardiovasc Res; 2013 Jul; 99(1):185-93. PubMed ID: 23554459
[TBL] [Abstract][Full Text] [Related]
3. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
4. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
5. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
6. miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation.
Kim S; Kang H
BMB Rep; 2013 Nov; 46(11):550-4. PubMed ID: 24152911
[TBL] [Abstract][Full Text] [Related]
7. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
[TBL] [Abstract][Full Text] [Related]
9. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.
Lin X; Zheng L; Song H; Xiao J; Pan B; Chen H; Jin X; Yu H
Exp Mol Pathol; 2017 Jun; 102(3):522-532. PubMed ID: 28506766
[TBL] [Abstract][Full Text] [Related]
10. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
An N; Zheng B
Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
[TBL] [Abstract][Full Text] [Related]
11. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
12. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
Kong D; Li Y; Wang Z; Banerjee S; Ahmad A; Kim HR; Sarkar FH
Stem Cells; 2009 Aug; 27(8):1712-21. PubMed ID: 19544444
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.
Ma L; Shao Z; Zhao Y
Pathol Res Pract; 2019 Jun; 215(6):152382. PubMed ID: 30890278
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
15. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
16. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
Xue L; Shen Y; Zhai Z; Zheng S
Int J Mol Med; 2020 Jun; 45(6):1771-1782. PubMed ID: 32236568
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression.
Xu B; Luo Y; Liu Y; Li BY; Wang Y
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H980-9. PubMed ID: 25724494
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
19. Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.
Yu HZ; Xie LD; Zhu PL; Xu CS; Wang HJ
Mol Cell Biochem; 2012 Jan; 360(1-2):363-71. PubMed ID: 21959973
[TBL] [Abstract][Full Text] [Related]
20. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.
Sureban SM; May R; Lightfoot SA; Hoskins AB; Lerner M; Brackett DJ; Postier RG; Ramanujam R; Mohammed A; Rao CV; Wyche JH; Anant S; Houchen CW
Cancer Res; 2011 Mar; 71(6):2328-38. PubMed ID: 21285251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
